advertisement
Ha A 13
Showing records 1 to 13 | Display all abstracts from Ha A78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim SN
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Ha A; Kim TJ
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ko SA; Park CG
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Girard MJA
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Lee SH
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Mari JM
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Huh BK
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Kim YK
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park YH
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Park KH
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim YK
Molecular pharmaceutics 2018; 15: 3143-3152
78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Jeoung JW
Ophthalmology 2018; 0:
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ha A; Park KH; Choy YB
Molecular pharmaceutics 2018; 15: 3143-3152
